Fundraising FoxBiotech Startups
11,050 companies tagged Biotech, with their investors and founders.
0 investors
San Francisco biotechnology company that filed a $400,000 Regulation D equity offering in April 2023.
0 investors
0 investors
Encore Medical develops cardiovascular medical devices, with clinical work focused on patent foramen ovale (PFO) and related conditions such as migraine. It operates in the cardiovascular medical device sector.
0 investors
0 investors
0 investors
Endonovo Therapeutics is a commercial-stage developer of non-invasive, wearable medical devices that deliver its Electroceutical Therapy, which uses bioelectricity to treat inflammatory conditions, cardiovascular diseases, and central nervous system disorders. Its therapy is FDA-cleared and CE-marked for pain, post-surgical edema, and wound healing, with a clinical-stage pipeline targeting ischemic heart disease, concussions, traumatic brain injury, and multiple sclerosis.
0 investors
0 investors
0 investors
Endotheia develops next-generation flexible endoscopy technology and products for medical procedures.
0 investors
ENDRA develops Thermo-Acoustic Enhanced UltraSound (TAEUS) technology, an ultrasound-based device for assessing and monitoring liver fat to help diagnose conditions such as NAFLD and NASH at the point of care. The technology is also aimed at other applications including visualizing tissue temperature during energy-based surgery and detecting arterial plaque or internal bleeding.
0 investors
0 investors
0 investors
Engraft Technologies develops surgical instruments for hair transplant surgery, including the Duplex Implanter, aimed at improving the safety, consistency, and efficiency of the procedure for practitioners. The company operates in the medical device and hair restoration field.
0 investors
0 investors
0 investors
0 investors
0 investors
Ensysce is a pharmaceutical development company focused on developing safer medicines, with particular expertise in pain management and opioid-related drug development. The team has extensive experience bringing targeted small molecule drugs and oncology compounds from discovery through clinical development to market approval.
0 investors
0 investors
0 investors
EnteroTrack develops the Esophageal String Test (EnteroTracker), a non-endoscopic, in-office test that measures eosinophil-associated proteins to generate an EoEScore for monitoring Eosinophilic Esophagitis (EoE). The device serves gastroenterologists and allergists as a surveillance tool that correlates with biopsy eosinophil counts and endoscopic severity.
0 investors
0 investors
0 investors